Aberdeen Israel Fund Inc  

(Public, NYSEMKT:ISL)   Watch this stock  
Find more results for Alan Israel�
16.70
+0.05 (0.30%)
Feb 27 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 16.61 - 16.70
52 week 15.18 - 18.60
Open 16.61
Vol / Avg. 511.00/4,718.00
Mkt cap 67.72M
P/E     -
Div/yield 0.20/1.19
EPS     -
Shares 4.23M
Beta 0.91
Inst. own 25%

Key stats and ratios

2010
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets - -
Return on average equity - -
CDP Score - -

Address

1735 Market St Fl 32
PHILADELPHIA, PA 19103-7503
United States - Map
+1-215-4052021 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aberdeen Israel Fund, Inc. is a closed-ended fund. The Fund seeks long-term capital appreciation by investing in equity securities of Israeli companies. It is the policy of the Fund to invest its assets in Israeli equity securities. For these purposes, Israeli securities includes common and preferred stock, warrants, options and debt securities organized under the laws of Israel. Aberdeen Asset Management Inc. is the Fund�s Investment Adviser.

Officers and directors

Enrique R. Arzac Ph.D. Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Christian A. J. Pittard President
Age: 41
Bio & Compensation  - Reuters
Andrea L. Melia Chief Financial Officer, Treasurer
Age: 45
Bio & Compensation  - Reuters
Jeffrey Cotton Vice President, Chief Compliance Officer
Age: 37
Bio & Compensation  - Reuters
Alan R. Goodson Vice President, Secretary
Age: 40
Bio & Compensation  - Reuters
Megan Kennedy Vice President, Secretary
Age: 40
Bio & Compensation  - Reuters
Joanne C. Irvine Vice President
Age: 46
Bio & Compensation  - Reuters
Devan Kaloo Vice President
Age: 43
Bio & Compensation  - Reuters
Jennifer A. Nichols Vice President
Age: 36
Bio & Compensation  - Reuters
Nick Robinson Vice President
Age: 36
Bio & Compensation  - Reuters